In contrast to ICH, the genetic deletion and/or pharmacological blockade of either the EP1 or FP receptor types attenuated brain injury and improved neurological outcomes in excitotoxicity and mouse ischemic stroke models (Ahmad et al., 2006, 2008; Saleem et al., 2007, 2009). Here, PTGER1 is linked to ischemic stroke.